系统性炎症生物标志物与高密度脂蛋白相关的评估:形患者的回顾性病例控制研究
Burçin Çakır1, Muhammed Muaz Osmanoğlu2, Büşra Güner Sönmezoğlu3
1Department of Ophthalmology, Sakarya Training and Research Hospital, Sakarya, Turkey. burcincakir@sakarya.edu.tr.
BMC ophthalmology
|December 24, 2025
概括
血小板与HDL比率 (PHR) 在角质 (KC) 患者中升高. 这项研究发现,在KC中,系统性炎症标志物和角膜拓图之间没有相关性.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 角膜 (KC) 是一种渐进的角膜脱膜症.
- 系统性炎症可能在KC病变发生中起作用.
- 高脂相关的炎症标志物需要在KC中进行进一步的研究.
研究的目的:
- 评估系统性炎症标志物,包括单细胞与高密度胆固醇比率 (MHR),中性粒细胞与高密度胆固醇比率 (NHR),淋巴细胞与高密度胆固醇比率 (LHR),中性粒细胞与淋巴细胞比率 (NLR) 和血小板与高密度胆固醇比率 (PHR),在KC患者中.
- 调查这些标记物与角膜地形参数之间的相关性.
主要方法:
- 对来自103名KC患者和99名对照患者的外周血液样本进行了回顾性分析.
- 平均MHR,NHR,LHR,NLR和PHR的计算方法.
- 评价角膜拓标志物及其与系统性炎症标志物的相关性.
主要成果:
- 与对照组相比,KC组的平均血小板与HDL比率 (PHR) 在KC组显著更高 (p=0.004).
- 确定了KC的最佳PHR切线值4807,具有74.8%的灵敏度和45.5%的特异性.
- 在角膜拓学参数和系统性炎症标志物之间没有发现显著的相关性.
结论:
- 在角质患者中,平均PHR升高.
- 在高脂相关的系统性炎症标志物和KC中的角膜拓之间没有相关性.
- 这项研究是第一个在形中探索HDL相关的系统性炎症标志物.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409


